Pegylated interferon 2a and ruxolitinib induce a high rate of oral complications among patients with myeloproliferative neoplasms

oleh: Marie Orliaguet, Sylvie Boisramé, Jean‐Richard Eveillard, Brigitte Pan‐Petesch, Marie‐Anne Couturier, Vincent Rebière, Gaelle Guillerm, Marie‐Caroline Le Bousse‐Kerdiles, Laurent Misery, Eric Lippert, Jean‐Christophe Ianotto